TABLE 6.
Evaluation of fever in patients suspected of having ventilator-associated pneumonia
Clinical circumstance | Management recommendation |
---|---|
Initial evaluation; clinically suspect VAPa | Calculate day 1 CPIS (see Table 2); routine care for suspected VAP (see Table 3); if febrile, consider other etiologies (see Table 4)b; immediate institution of antimicrobial treatment after cultures performedc |
Reevaluation at 48-72 h | Calculate day 3 CPIS (see Table 2) |
(i) High likelihood of VAP (see Table 5) or (ii) nonpulmonary site | |
of infection identified or (iii) unexplained severe sepsisd | Continue antibiotics; adjust regimen based on culture results and probable site(s) of infectionb |
Chest X-ray infiltrates no longer presente; severe sepsis absent now | |
and initially; no nonpulmonary site of infection identified | Discontinue antibiotics and follow patient; if still febrile, search for etiologyb |
Non- or semiquantitative culture strategy | |
(i) Day 1 CPIS of >6 and ETA culture positive or (ii) day 1 CPIS | |
of ≤6 and day 3 CPIS of >6 | Continue antibiotics; adjust regimen based on culture results |
Day 1 CPIS of ≤6 and day 3 CPIS of ≤6 and: | |
Cultures negative and antibiotics have not been changed or added | |
in the 72 h prior to obtaining cultures (VAP unlikely) | Discontinue antibiotics and follow patient; if still febrile, search for etiologyb |
(i) Cultures negative and antibiotics have been changed or added | |
in the 72 h prior to obtaining cultures or (ii) cultures positive | No firm recommendation; consider discontinuing antibiotics and following patientf (favored); if still febrile, search for etiologyb |
Day 1 CPIS of >6 and ETA culture negative | No firm recommendation; consider discontinuing antibiotics and following if antibiotics have not been changed in the 72 h prior to obtaining cultures, particularly if alternative, noninfectious diagnosis confirmed; otherwise, continue antibiotics; if still febrile, search for etiologyb |
Quantitative culture strategy | |
Colony count exceeds threshold (VAP likely)g | Continue antibiotics; adjust regimen based on culture results |
Colony count below threshold and: | |
Antibiotics have not been changed or added in the 72 h prior | |
to obtaining cultures (VAP unlikely)h | Discontinue antibiotics and follow patient; if still febrile, search for etiologyb |
Antibiotics have been changed or added in the 72 h prior | |
to obtaining cultures | No firm recommendations; if still febrile, search for etiologyb |
Day 1 CPIS of ≤6 and day 3 CPIS of ≤6 | Consider discontinuing antibiotics and following patientf (favored) |
Factors increasing probability of true-negative result | |
are presenth | Consider discontinuing antibiotics and following patient |
CPIS on day 1 of >6 (see Table 2) and in the setting of ARDS, one or more of the following clinical parameters: new and persistent (>48 h) or progressive radiographic infiltrate, temperature of >38°C or <36°C, blood leukocyte count of >10,000 cells/ml or <5,000 cells/ml, purulent tracheal secretions, unexplained hemodynamic instability, or unexplained deterioration in oxygenation status.
Consider that patient may have more than one explanation for fever.
Rationale: delayed treatment of VAP increases mortality.
Rationale: a definite site of infection cannot be found in 20 to 30% of patients with sepsis; delayed treatment of severe sepsis increases mortality.
Rationale: infiltrates secondary to pneumonia do not improve in 72 h; consider atelectasis, congestive heart failure, hemorrhage, or chemical pneumonitis as the cause of pulmonary infiltrates.
Rationale: based on reference 183.
Factors increasing probability of a true-positive result: colony count more than 101 CFU/ml above threshold, presence of distal purulent secretions or persistence of distal secretions surging from distal bronchi during exhalation after bronchoscopic aspiration, >50% neutrophils on BAL, and >10% neutrophils and <1% epithelial cells on direct examination of BAL, PSB, or PTC.
Factors increasing probability of a true-negative result: colony count more than 101 CFU/ml below threshold, absence of distal purulent secretions or persistence of distal secretions surging from distal bronchi during exhalation, <50% neutrophils on BAL differential, and <10% neutrophils and <1% epithelial cells on direct examination of BAL, PSB, or PTC.